Testing effectiveness (Phase 2)Study completedNCT00211276What this trial is testingONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's LymphomaWho this might be right forLymphoma, B-Cell Eisai Inc. 50
Early research (Phase 1)Ended earlyNCT04702425What this trial is testingVOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma)Who this might be right forNon-Hodgkin Lymphoma (NHL)Acute Myeloid Leukemia (AML)Multiple Myeloma (MM) Novartis Pharmaceuticals 37
Very early researchUnknownNCT04412174What this trial is testingGC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHLWho this might be right forB-cell Non Hodgkin Lymphoma Hebei Yanda Ludaopei Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00002510What this trial is testingChemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Temple University
Testing effectiveness (Phase 2)Study completedNCT00169208What this trial is testingFludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's LymphomaWho this might be right forFollicular Lymphoma Lymphoma Study Association 50
Early research (Phase 1)Study completedNCT01943682What this trial is testingSafety Study of CPX-351 in Children With Relapsed Leukemia or LymphomaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBurkitt Lymphoma+5 more Children's Hospital Medical Center, Cincinnati 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565417What this trial is testingStudy of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasWho this might be right forNon Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaTriple Negative Breast Cancer+9 more Immunitas Therapeutics 67
Testing effectiveness (Phase 2)Study completedNCT02593123What this trial is testingAdoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD ProphylaxisWho this might be right forHodgkin's LymphomaLymphoid LeukemiaLymphoma+15 more Virginia Commonwealth University 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07607925What this trial is testingEvaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHLWho this might be right forLymphoma, Non-Hodgkin GlaxoSmithKline 49
Early research (Phase 1)Study completedNCT03027284What this trial is testingMerestinib (LY2801653) in Japanese Participants With Advanced or Metastatic CancerWho this might be right forAdvanced CancerMetastatic CancerBiliary Tract Carcinoma+4 more Eli Lilly and Company 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05020015What this trial is testingTAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)Who this might be right forRelapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) Takeda 27
Testing effectiveness (Phase 2)Study completedNCT00005040What this trial is testingArsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT05466318What this trial is testingChiCGB vs BEAM in High-risk or R/R LymphomasWho this might be right forLymphoma, Large B-Cell, DiffuseLymphoma, T-Cell Sichuan University 306
Large-scale testing (Phase 3)UnknownNCT00017290What this trial is testingCombination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's LymphomaWho this might be right forLymphoma Genitope Corporation
Early research (Phase 1)Study completedNCT01273090What this trial is testingImetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more Children's Oncology Group 34
Large-scale testing (Phase 3)Study completedNCT00003150What this trial is testingCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Eastern Cooperative Oncology Group 630
Testing effectiveness (Phase 2)Study completedNCT01177397What this trial is testingStudy to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple MyelomaWho this might be right forMultiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more Celgene 226
Early research (Phase 1)Looking for participantsNCT06565689What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012Who this might be right forRelapsed or Refractory B-Cell Non-Hodgkin Lymphoma Excyte Biopharma Ltd 48
Early research (Phase 1)Looking for participantsNCT06859008What this trial is testingZanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecurrent Diffuse Large B-Cell Lymphoma+16 more City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT01118013What this trial is testingDonor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantWho this might be right forLeukemiaLymphomaLymphoproliferative Disorder+3 more Alliance for Clinical Trials in Oncology 6